CRBP
Corbus Pharmaceuticals Holdings, Inc.
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Corbus Pharmaceuticals (CRBP) Stock: Buy, Sell, or Hold?
$3.39
-0.02 (-0.59%)
▼
5d:
+10.42%
30d:
-21.71%
90d:
-67.68%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (80%)
Quality Score
41/100
Position
OVERSOLD
30-Day Fair Range
$3.54 – $4.83
Position: OVERSOLD
Forward P/E & Valuation
-0.6x
Next 12M consensus est.
Wall Street Target
$33.22
+880.0% upside
Options IV & Volume
66th pct IV
HIGH volume confirmation
Support / Resistance
$2.81 / $4.23
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: CRBP shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When CRBP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CRBP is currently trading at $3.39, which is considered oversold relative to its 30-day fair value range of $3.54 to $4.83.
Technical Outlook: Technically, CRBP is in a strong downtrend. Immediate support is located at $2.81, while resistance sits at $4.23.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $33.22 (+880.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRBP is in a strong downtrend. Immediate support is located at $2.81, while resistance sits at $4.23.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $33.22 (+880.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.54 -
$4.83
Company Quality Score
41/100
(HOLD)
Options IV Signal
66th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
80.0%
Trading Range & Key Levels
30-Day Trading Range
$3.54 -
$4.83
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.68
(20.1%)
Support Level
$2.81
Resistance Level
$4.23
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Institutional Signals, 13F Whale Activity & Setup Structure
Quantitative Research Feed
Phase & Gamma Walls
BREAKDOWN
Days in Phase:
57d (52% conf)
30D Insider Cluster Signal
TRACKED
30D Insider Buyers:
0 insiders ($0)
30D Net Insider Flow:
$-1,742,755
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 66th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 880.0% below Wall St target ($33.22)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.64
Wall Street Target
$33.22
(+880.0%)
Revenue Growth (YoY)
-100.0%
Share CRBP Analysis
Share this live CRBP analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CRBP)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
Corbus Pharmaceuticals reported a wider-than-expected loss in Q3 2026, with a loss per share of $1.81 versus the expected $1.45.
Key Retail Themes:
earnings report
financial performance
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 15, 2026 8:49 PM ET
Data refreshes hourly during market hours. Next update: 9:49 PM
Data refreshes hourly during market hours. Next update: 9:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRBP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 49 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
24 analysts |
$1147 | 33 SELL |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 35 SELL |
|
ARDX
Ardelyx Inc |
STRONG BUY
11 analysts |
$13 | 69 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CRBP Research Pages
Part B: Tradestie Flagship Market Scanners